These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10683073)

  • 1. A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma: a Penn Cancer Clinical Trials Group (PCCTG) trial.
    David AK; Vaughn DJ; Holroyde CP; Armstead B; Haller DG
    Am J Clin Oncol; 2000 Feb; 23(1):37-9. PubMed ID: 10683073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
    Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A
    Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
    Shapiro JD; Harold N; Takimoto C; Hamilton JM; Vaughn D; Chen A; Steinberg SM; Liewehr D; Allegra C; Monahan B; Lash A; Grollman F; Flemming D; Behan K; Johnston PG; Haller D; Quinn M; Morrison G; Grem JL
    Clin Cancer Res; 1999 Sep; 5(9):2399-408. PubMed ID: 10499610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatin.
    Sporn JR; Buzaid AC; Slater D; Cohen N; Greenberg BR
    Am J Clin Oncol; 1997 Feb; 20(1):81-3. PubMed ID: 9020295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer.
    Moore MJ; Erlichman C; Kaizer L; Fine S
    Anticancer Drugs; 1993 Oct; 4(5):555-7. PubMed ID: 8292812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.
    Grem JL; Jordan E; Robson ME; Binder RA; Hamilton JM; Steinberg SM; Arbuck SG; Beveridge RA; Kales AN; Miller JA
    J Clin Oncol; 1993 Sep; 11(9):1737-45. PubMed ID: 8355041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of fluorouracil and recombinant alpha-2a-interferon in previously untreated patients with pancreatic adenocarcinoma.
    Pazdur R; Ajani JJ; Abbruzzese JL; Belt RJ; Dakhil SR; Dubovsky D; Graham S; Pilat S; Winn R; Levin B
    Cancer; 1992 Oct; 70(8):2073-6. PubMed ID: 1394037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M
    Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination fluorouracil, folinic acid, and interferon alfa-2a: an active regimen in advanced pancreatic carcinoma.
    Knuth A; Bernhard H; Klein O; Meyer zum Büschenfelde KH
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):211-4. PubMed ID: 1557650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.
    Wolmark N; Bryant J; Smith R; Grem J; Allegra C; Hyams D; Atkins J; Dimitrov N; Oishi R; Prager D; Fehrenbacher L; Romond E; Colangelo L; Fisher B
    J Natl Cancer Inst; 1998 Dec; 90(23):1810-6. PubMed ID: 9839521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
    Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP
    Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma.
    Bukowski RM; Inoshita G; Yalavarthi P; Murthy S; Gibson V; Budd GT; Sergi JS; Bauer L; Prestifilippo J
    Cancer; 1992 Feb; 69(4):889-92. PubMed ID: 1735080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.
    Soori GS; Oldham RK; Dobbs TW; Bury MJ; Church CK; DePriest C
    Cancer Biother Radiopharm; 2000 Apr; 15(2):175-83. PubMed ID: 10803323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
    Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML
    Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil, leucovorin and interferon alpha 2b in advanced pancreatic cancer: a pilot study.
    Cascinu S; Fedeli A; Fedeli SL; Catalano G
    Ann Oncol; 1993 Jan; 4(1):83-4. PubMed ID: 8435370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas.
    Scheithauer W; Pfeffel F; Kornek G; Marczell A; Wiltschke C; Funovics J
    Cancer; 1992 Oct; 70(7):1864-6. PubMed ID: 1525760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413).
    Macdonald JS; Jacobson JL; Modiano M; Moore DF; Gandara DR; Schroder LE; Chapman RA
    Invest New Drugs; 2000 Aug; 18(3):269-73. PubMed ID: 10958597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292.
    Sparano JA; Lipsitz S; Wadler S; Hansen R; Bushunow PW; Kirkwood J; Flynn PJ; Dutcher JP; Benson AB
    Am J Clin Oncol; 1996 Dec; 19(6):546-51. PubMed ID: 8931668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.